| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Center for Complementary and Alternative Medicine (NCCAM) |
| Information provided by: | National Center for Complementary and Alternative Medicine (NCCAM) |
| ClinicalTrials.gov Identifier: | NCT00067678 |
Purpose
Diabetic nephropathy is a frequent cause of end-stage renal disease. Reduction of dietary protein has been used to slow down renal disease progression, but patients are often unwilling to make these dietary changes. Other research suggests that changing the quality of dietary protein may be as effective as reducing the total amount of ingested protein. This study hopes to show that soy protein, a plant protein relatively high in essential amino acids and with high nutritional value, maye be beneficial to Type I diabetic patients with incipient renal disease.
| Condition | Intervention | Phase |
|
Diabetic Nephropathy Diabetes Mellitus |
Drug: soy protein |
Phase I Phase II |
| MedlinePlus related topics: | Diabetes Diabetic Kidney Problems |
| Drug Information available for: | Proteins, soy |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
| Official Title: | Soy Protein in Early Diabetic Nephropathy |
Eligibility
| Ages Eligible for Study: | 18 Years to 40 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion criteria:
Contacts and Locations More Information
| Study ID Numbers: | R21 AT000323-01 |
| First Received: | August 25, 2003 |
| Last Updated: | August 16, 2006 |
| ClinicalTrials.gov Identifier: | NCT00067678 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|
